University Of Notre Dame Du Lac United Therapeutics Corp Transaction History

University Of Notre Dame Du Lac

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $1.66 Million - $2.63 Million	-21,784 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $217,835 - $257,865	2,033 Added 10.29%	21,784 $2.56 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $282,601 - $358,770	-2,787 Reduced 12.37%	19,751 $2.15 Million
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $357,363 - $406,504	-3,140 Reduced 12.23%	22,538 $2.88 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $680,874 - $796,462	6,732 Added 35.53%	25,678 $2.91 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $336,532 - $476,939	-3,139 Reduced 14.21%	18,946 $2.13 Million
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $296,094 - $377,746	2,497 Added 12.75%	22,085 $3.27 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $2.24 Million - $2.68 Million	19,588	19,588 $2.3 Million

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.